Richard A Meier insider trades: Biomarin Pharmaceutical (BMRN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
and 3 more companies
Open-market buys and sales
27 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 2, 2022 | BMRN | ↓ Sell | 3,878 | $82.09 | $318K | Direct | May 4, 2022 (2d) |
| May 6, 2021 | BMRN | ↓ Sell | 5,068 | $78.38 | $397K | Direct | May 7, 2021 (1d) |
| Mar 17, 2020 | XENT | ↑ Buy | 5,000 | $7.80 | $39K | Direct | Mar 17, 2020 (0d) |
| Mar 16, 2020 | XENT | ↑ Buy | 10,000 | $12.55 | $125K | Direct | Mar 17, 2020 (1d) |
| Sep 13, 2018 | BMRN | ↓ Sell | 3,000 | $99.24 | $298K | Direct | Sep 17, 2018 (4d) |
| Aug 27, 2018 | BMRN | ↓ Sell | 2,000 | $100.12 | $200K | Direct | Aug 29, 2018 (2d) |
| May 20, 2016 | STAA | ↓ Sell | 25,000 | $5.35 | $134K | Direct | May 23, 2016 (3d) |
| May 7, 2014 | OMI | ↑ Buy | 2,500 | $32.50 | $81K | Direct | May 8, 2014 (1d) |
| Feb 28, 2014 | OMI | ↑ Buy | 2,500 | $34.85 | $87K | Direct | Mar 3, 2014 (3d) |
| Feb 19, 2013 | BMRN | ↓ Sell | 5,000 | $57.50 | $288K | Direct | Feb 21, 2013 (2d) |
| Jan 2, 2013 | BMRN | ↓ Sell | 10,000 | $51.25 | $513K | Direct | Jan 4, 2013 (2d) |
| Dec 11, 2012 | BMRN | ↓ Sell | 5,000 | $49.71 | $249K | Direct | Dec 13, 2012 (2d) |
| Nov 29, 2012 | BMRN | ↓ Sell | 5,000 | $49.17 | $246K | Direct | Dec 3, 2012 (4d) |
| Mar 19, 2010 | TFX | ↑ Buy | 5,000 | $63.10 | $315K | Direct | Mar 22, 2010 (3d) |
| Dec 8, 2009 | STAA | ↑ Buy | 5,000 | $2.94 | $15K | Direct | Dec 8, 2009 (0d) |
| Aug 13, 2009 | STAA | ↑ Buy | 10,000 | $3.15 | $31K | Direct | Aug 13, 2009 (0d) |
| Aug 10, 2009 | STAA | ↑ Buy | 10,000 | $2.75 | $28K | Direct | Aug 10, 2009 (0d) |
| Jun 5, 2009 | BMRN | ↑ Buy | 2,000 | $13.70 | $27K | Direct | Jun 9, 2009 (4d) |
| Mar 13, 2009 | BMRN | ↑ Buy | 1,000 | $11.45 | $11K | Direct | Mar 17, 2009 (4d) |
| Mar 3, 2009 | BMRN | ↑ Buy | 2,000 | $10.93 | $22K | Direct | Mar 4, 2009 (1d) |
| Aug 7, 2008 | EYE | ↑ Buy | 2,000 | $19.25 | $39K | Direct | Aug 7, 2008 (0d) |
| May 23, 2008 | EYE | ↑ Buy | 2,000 | $22.50 | $45K | Direct | May 23, 2008 (0d) |
| Nov 2, 2007 | EYE | ↑ Buy | 1,000 | $25.99 | $26K | Direct | Nov 2, 2007 (0d) |
| Oct 31, 2007 | EYE | ↑ Buy | 2,000 | $27.38 | $55K | Direct | Oct 31, 2007 (0d) |
| Aug 23, 2007 | EYE | ↑ Buy | 2,000 | $28.30 | $57K | Direct | Aug 24, 2007 (1d) |
| Aug 15, 2007 | EYE | ↑ Buy | 10,000 | $29.50 | $295K | Direct | Aug 15, 2007 (0d) |
| Nov 29, 2005 | EYE | ↑ Buy | 5,000 | $41.95 | $210K | Direct | Nov 29, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BMRN insiders
Open-market trades in the last 12 months
About Richard A Meier's insider trades
Richard A Meier is a director at Biomarin Pharmaceutical (BMRN). Since Nov 29, 2005, Richard has reported 18 open-market purchases worth $1.5M and 9 sales worth $2.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (53 filings), option exercises (12 filings), shares withheld for taxes (10 filings), gifts (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BMRN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.